Skip to content

NRXP

NRX Pharmaceuticals, Inc.

NASDAQ · Healthcare · Biotechnology · US

$2.63
+1.15%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
17.90x
P/S forward
1.09x

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
-669.81x
Price / sales
33.55x
Price / cash flow
-5.76x

Enterprise value

Enterprise value
$88.4M
EV / sales
26.05x
EV / EBITDA
-4.05x
EV / EBIT
-4.43x
Market cap
$113.9M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026